Novartis to Acquire the Remaining Stake in Chiron
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 66 (Table of Contents)
Published: 5 Dec-2005
DOI: 10.3833/pdr.v2005.i66.595 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Novartis entered into merger agreement with Chiron thus strengthening its product portfolio with vaccines, Chiron’s blood tests, marketed products of oncology, cystic fibrosis and multiple sclerosis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS